Preliminary Safety, Efficacy and Molecular Characterization in Patients with Higher-Risk Myelodysplastic Syndrome Treated with…
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide
Read Article
Sequential Therapy…
Abstract C095: [212Pb]VMT-a-NET for somatostatin receptor subtype 2 (SSTR2)-expressing tumors: safety and preliminary efficacy…
ACE-BREAST-03: A phase 2 trial evaluating ARX788, an anti-HER2 antibody drug conjugate (ADC), for…
Winter in Nebraska often means chilly days and cozy nights—and it’s the perfect time…
The holiday season is often filled with joy, celebration, and connection. Yet, for individuals…
OMAHA, Neb. — Nebraska Cancer Specialists (NCS) is proud to announce the opening of…
OMAHA, Neb. — Nebraska Cancer Specialists (NCS) is proud to continue its commitment to…
Just over a year ago Nebraska Cancer Specialists, located inside CHI Health Regional Cancer Center…
Purpose  •  Innovation  •  Relationship  •  Excellence
© 2026 Nebraska Cancer Specialists  • Privacy Policy • design by Chip Thompson
Meet DOT.